Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
2
×
astrazeneca
2
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
2
×
detroit blog main
detroit top stories
eli lilly
fda
gene therapy
indiana blog main
indiana top stories
johnson & johnson
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
2
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
10x genomics
abbvie
abeona therapeutics
achaogen
affordable care act
allergan
What
bio
roundup
2
×
alzheimer’s
august
biotech
busy
congress
days
decisions
democrats
devices
divided
drugs
elections
fallout
fda
legacy
losses
midterm
news
nods
opioid
panel
past
plenty
political
postpartum
regulatory
sarepta’s
search
seven
shkreli’s
slow
stake
stumble
suits
tends
terms
took
week’s
Language
unset
Current search:
amgen
×
roundup
×
novartis
×
" clinical trials "
×
astrazeneca
×
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel